The University of Alabama at Birmingham, in conjunction with researchers at the University of Wisconsin and Argonne National Laboratory in Illinois, have received a Department of Energy grant to solve a production roadblock for the radioactive isotopes 43Sc and 47Sc. These radioactive isotopes of the metallic element scandium (Sc) appear to be ideal for visualizing and then destroying solid tumors. A barrier, however, blocks their use — the inability to rapidly produce and purify the isotopes in useful amounts. 43Sc has a half-life of 3.9 hours, so every four hours more than half the radioactivity is lost. It must be used in a positron emission tomography (PET) scan the same day it is made.

X-ray therapy systems developer Xstrahl announced the launch of the new SARRP (small animal radiation research platform) beamline pre-clinical radiation research and computed tomography (CT) imaging platform. The system was launched at the 2019 International Congress of Radiation Research (ICRR), Aug. 25-29 in Manchester, U.K.

A new 3-D magnetic resonance imaging (MRI) computing technique developed by scientists in WMG at the University of Warwick focuses on hierarchical template matching (HTM) to diagnose cardiac disease without the use of gadolinium contrast. The technique is explored in an article in the journal Scientific Reports.

UCHealth Greeley Hospital of Greeley, Colo., recently became the first healthcare facility in the United States to adopt the Mobilett Elara Max mobile X-ray system from Siemens Healthineers. The Mobilett Elara Max enables comprehensive information technology (IT) security as well as secure system integration into the hospital’s IT environment. UCHealth Greeley has installed two Mobilett Elara Max systems: a standard model and a pediatric-friendly version featuring a giraffe design.UCHealth Greeley Hospital of Greeley, Colo., recently became the first healthcare facility in the United States to adopt the Mobilett Elara Max mobile X-ray system from Siemens Healthineers. The Mobilett Elara Max enables comprehensive information technology (IT) security as well as secure system integration into the hospital’s IT environment. UCHealth Greeley has installed two Mobilett Elara Max systems: a standard model and a pediatric-friendly version featuring a giraffe design.

Fujifilm Medical Systems U.S.A. Inc. recently announced that Ashley County Medical Center (Crossett, Ark.) has invested in new upgrades to its Fujifilm Aspire Cristalle digital mammography solution. Fujifilm upgraded Ashley County Medical Center’s Aspire Cristalle unit with digital breast tomosynthesis (DBT), making it the first Fujifilm 3-D digital mammography solution to be installed in Arkansas.

August 27, 2019 — Medical data delivery company Royal Solutions has partnered with ZipRad to streamline imaging exam order entry. Referring physicians can now print orders directly from their electronic health record (EHR) without the need for faxing, expensive, resource-intensive HL7 implementations and without having to re-enter information into a different portal. 

According to ZipRad, the company’s three-step solution takes less than 60 seconds:

Radiation dosimetry company announced plans to exhibit its full range of radiation therapy dosimetry solutions for acceptance, commissioning, beam data acquisition and patient-specific quality assurance (QA) at the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-19 in Chicago.

A new Harvey L. Neiman Health Policy Institute study assesses temporal and patient-level differences in paracentesis and thoracentesis procedures performed on Medicare beneficiaries by radiologists and non-radiologists with respect to overall procedure volume, day of week and patient complexity. The study is published online in Journal of Vascular and Interventional Radiology.

Ultrasound imaging company Terason has partnered with DiA Imaging Analysis, provider of artificial intelligence (AI)-based solutions for ultrasound analysis, to provide its cardiac solutions on Terason's point-of-care ultrasound devices.

The U.S. Food and Drug Administration (FDA) released a new draft guidance that encourages including male patients in breast cancer clinical trials. The document provides recommendations to sponsors on the development and labeling of cancer drugs, including biological products, for the treatment of male patients with breast cancer.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now